Integrated approaches to close the loop in type 1 diabetes

闭合 1 型糖尿病循环的综合方法

基本信息

  • 批准号:
    7788333
  • 负责人:
  • 金额:
    $ 71.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary Integrated Approaches to close the loop in Type 1 diabetes. The RFA 08-012 emphasizes closing the loop in type 1 diabetes mellitus (T1DM), an endeavor that will depend on developing physiological models that will evaluate the reasons for glycemic variability using state of the art technologic approaches so that continuous subcutaneous insulin infusion (CSII) algorithms are better informed. The physiology studies need to be directed towards understanding the impact of variability introduced by circadian and intra-individual differences in post prandial insulin action, variability in the timing and rate of appearance of ingested carbohydrates into the systemic circulation and variability introduced by changes in physical activity. Using innovative specific activity clamps to minimize non steady state errors, we have recently developed and validated a triple tracer technique to measure post prandial peripheral and hepatic insulin action and rate of appearance of meal derived glucose. We have also developed and validated tools (eg., accelerometers, physical activity monitoring systems) to accurately capture daily physical activity. In this context, and utilizing the above techniques, the following specific aims will be addressed: 1) We will determine whether circadian pattern of post prandial insulin action and meal glucose appearance occurs in T1DM and the extent to which it differs from nondiabetic healthy subjects. We will also take this opportunity to further develop and validate a novel single tracer method to measure post prandial glucose kinetics. 2) We will explore if gastric emptying rate can predict post prandial meal glucose appearance, insulin action and 24 hour glucose variability in T1DM. To do so, we will screen for abnormalities in gastric emptying then use the tripe tracer method (or single tracer model if validated in aim 1) to determine if asymptomatic changes in gastric emptying are accompanied by changes in the timing and systemic rate appearance of ingested glucose and if so, the extent to which changes in the pattern of meal appearance predict post prandial hyperglycemia and glucose variability as measured using CGM parameters. This is an important variable to consider since abnormal gastric motility is frequently observed in asymptomatic individuals with T1DM. 3) We will evaluate the impact of low and moderate intensity physical activity on glucose variability, post prandial meal glucose appearance and insulin action in T1DM. To do so, we will assess the impact of low and moderate intensity exercise (measured by accelerometers) on glucose variability using CGM parameters (high and low blood glucose indices), meal glucose appearance and post prandial insulin action. We will take this opportunity to further modify tracer technique if necessary to clamp specific activity in order to accurately estimate insulin action in the post prandial state. Summary and Significance: Glucose variability and frequent hypoglycemia are major factors that limit optimal subcutaneous insulin delivery in T1DM. In this application, we propose to utilize and further innovate existing cutting edge techniques to develop a physiological model whereby daily variations in post prandial insulin action, gastric motility and physical activity captured with precise physical activity monitoring systems, e.g., accelerometers, are integrated to facilitate development of a model predictive control algorithm of individualized "closed loop system" of insulin delivery. PUBLIC HEALTH RELEVANCE: The insulin pump and the glucose sensor have had limited impact on control of blood sugar and quality of life in type 1 diabetes mellitus (T1DM). This is because of limited knowledge of the effects of daily variation in efficiency of insulin action, stomach emptying capacity and physical activity on daily fluctuations in blood sugar in T1DM. Using innovative and cutting edge technologies, we will investigate the effects of all of these factors on sugar metabolism and fluctuations in blood sugar in people with T1DM on the insulin pump and glucose sensor and simultaneously initiate the use of new technology such as highly accurate accelerometers to capture physical activity. We believe that information obtained from our research will result in the development of a first generation endocrine artificial pancreas.
描述(由申请人提供):项目总结:1型糖尿病闭环的综合方法。RFA 08-012强调1型糖尿病(T1DM)的闭合循环,这一努力将依赖于开发生理模型,利用最先进的技术方法评估血糖变化的原因,以便更好地了解持续皮下胰岛素输注(CSII)算法。生理学研究的方向是理解由昼夜节律和餐后胰岛素作用的个体内差异、摄入碳水化合物进入体循环的时间和速率的可变性以及身体活动变化带来的可变性所带来的影响。我们最近开发并验证了一种三重示踪技术,用于测量餐后外周和肝脏胰岛素的作用以及餐源性葡萄糖的出现率。我们还开发并验证了工具(例如。(如加速度计、身体活动监测系统),以准确捕捉每天的身体活动。在这种情况下,利用上述技术,将解决以下具体目标:1)我们将确定T1DM患者餐后胰岛素作用和膳食葡萄糖外观的昼夜节律模式是否发生,以及它与非糖尿病健康受试者的差异程度。我们也将借此机会进一步开发和验证一种新的单一示踪剂方法来测量餐后葡萄糖动力学。2)我们将探讨胃排空率是否可以预测T1DM患者餐后血糖表现、胰岛素作用和24小时血糖变异性。为此,我们将筛选胃排空异常,然后使用三联示踪剂方法(或单示踪剂模型,如果在目标1中得到验证)来确定胃排空的无症状变化是否伴随着摄入葡萄糖的时间和全身速率的变化,如果是这样,进餐外观模式的变化在多大程度上预测餐后高血糖和使用CGM参数测量的葡萄糖变异性。这是一个需要考虑的重要变量,因为在无症状的T1DM患者中经常观察到胃运动异常。3)我们将评估低强度和中等强度体力活动对T1DM患者血糖变异性、餐后血糖表现和胰岛素作用的影响。为此,我们将利用CGM参数(高血糖指数和低血糖指数)、膳食葡萄糖外观和餐后胰岛素作用来评估低强度和中等强度运动(通过加速度计测量)对葡萄糖变异性的影响。如果有必要,我们将借此机会进一步改进示踪技术,以箝制特定活性,以便准确估计餐后状态下胰岛素的作用。总结与意义:血糖变异性和频繁的低血糖是限制T1DM患者最佳皮下胰岛素输送的主要因素。在这项应用中,我们建议利用并进一步创新现有的前沿技术来开发一种生理模型,通过精确的身体活动监测系统(如加速度计)捕获餐后胰岛素作用、胃运动和身体活动的日常变化,从而促进胰岛素输送个性化“闭环系统”的模型预测控制算法的开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANANDA BASU其他文献

ANANDA BASU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANANDA BASU', 18)}}的其他基金

Glucagon Pump Therapy for Post-Bariatric Hypoglycemia: Merging Physiology and Engineering
胰高血糖素泵治疗减肥后低血糖:生理学与工程学的结合
  • 批准号:
    10754041
  • 财政年份:
    2023
  • 资助金额:
    $ 71.55万
  • 项目类别:
Relative Efficacy of Single-, Bi-, and Tri-Hormonal Closed-Loop Control Systems
单激素、双激素和三激素闭环控制系统的相对功效
  • 批准号:
    8969719
  • 财政年份:
    2015
  • 资助金额:
    $ 71.55万
  • 项目类别:
Ambulatory Artificial Pancreas: merging physiology, behavior, and control design
动态人工胰腺:融合生理学、行为和控制设计
  • 批准号:
    8796554
  • 财政年份:
    2014
  • 资助金额:
    $ 71.55万
  • 项目类别:
Ambulatory artificial pancreas: merging physiology, behavior, and controldesign
动态人工胰腺:融合生理学、行为和控制设计
  • 批准号:
    8241344
  • 财政年份:
    2011
  • 资助金额:
    $ 71.55万
  • 项目类别:
Integrated approaches to close the loop in type 1 diabetes
闭合 1 型糖尿病循环的综合方法
  • 批准号:
    8136077
  • 财政年份:
    2009
  • 资助金额:
    $ 71.55万
  • 项目类别:
Integrated approaches to close the loop in type 1 diabetes
闭合 1 型糖尿病循环的综合方法
  • 批准号:
    8537427
  • 财政年份:
    2009
  • 资助金额:
    $ 71.55万
  • 项目类别:
Integrated approaches to close the loop in type 1 diabetes
闭合 1 型糖尿病循环的综合方法
  • 批准号:
    7940798
  • 财政年份:
    2009
  • 资助金额:
    $ 71.55万
  • 项目类别:
Integrated approaches to close the loop in type 1 diabetes
闭合 1 型糖尿病循环的综合方法
  • 批准号:
    8326735
  • 财政年份:
    2009
  • 资助金额:
    $ 71.55万
  • 项目类别:
PIOGLITAZONE ON BODY COMPOSITION, ENERGY BALANCE, VASCULAR FUNCTION AND MEAL TOL
吡格列酮对身体成分、能量平衡、血管功能和进餐时间的影响
  • 批准号:
    7206112
  • 财政年份:
    2005
  • 资助金额:
    $ 71.55万
  • 项目类别:
MEASUREMENT OF NITRIC OXIDE IN HUMANS: A PILOT STUDY
人体一氧化氮的测量:一项试点研究
  • 批准号:
    7206169
  • 财政年份:
    2005
  • 资助金额:
    $ 71.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了